Consistent with previous studies, our results demonstrated a reduction in the co-localized area of Iba-1 and CD68, which are markers of activated microglia, in the peri-infarct region of NPC-treated animals. The gene discussed is CD68; the disease is nasopharyngeal carcinoma.